• Maria E Laucho-Contreras, Francesca Polverino, Kushagra Gupta, Katherine L Taylor, Emer Kelly, Victor Pinto-Plata, Miguel Divo, Naveed Ashfaq, Hans Petersen, Barry Stripp, Aprile L Pilon, Yohannes Tesfaigzi, Bartolome R Celli, and Caroline A Owen.
• Pulmonary Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA These authors contributed equally to this manuscript.
• Eur. Respir. J. 2015 Jun 1; 45 (6): 1544-56.

AbstractClub cell secretory protein-16 (CC16) is the major secreted product of airway club cells, but its role in the pathogenesis of chronic obstructive pulmonary disease (COPD) is unclear. We measured CC16 airway expression in humans with and without COPD and CC16 function in a cigarette smoke (CS)-induced COPD murine model. Airway CC16 expression was measured in COPD patients, smokers without COPD and non-smokers. We exposed wildtype (WT) and CC16(-/-)mice to CS or air for up to 6 months, and measured airway CC16 expression, pulmonary inflammation, alveolar septal cell apoptosis, airspace enlargement, airway mucin 5AC (MUC5AC) expression, small airway remodelling and pulmonary function. Smokers and COPD patients had reduced airway CC16 immunostaining that decreased with increasing COPD severity. Exposing mice to CS reduced airway CC16 expression. CC16(-/-) mice had greater CS-induced emphysema, airway remodelling, pulmonary inflammation, alveolar cell apoptosis, airway MUC5AC expression, and more compliant lungs than WT mice. These changes were associated with increased nuclear factor-κB (NF-κB) activation in CC16(-/-) lungs. CS-induced acute pulmonary changes were reversed by adenoviral-mediated over-expression of CC16. CC16 protects lungs from CS-induced injury by reducing lung NF-κB activation. CS-induced airway CC16 deficiency increases CS-induced pulmonary inflammation and injury and likely contributes to the pathogenesis of COPD. Copyright ©ERS 2015.

40 keywords...

hide…